A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesoth...
A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma
About this item
Full title
Author / Creator
Publisher
Dove Medical Press Limited
Journal title
Language
English
Formats
Publication information
Publisher
Dove Medical Press Limited
Subjects
More information
Scope and Contents
Contents
Purpose: Malignant pleural mesothelioma (MPM) is a rare malignancy with a dismal median survival of <12 months with current therapy. Single and combination chemotherapy regimens have shown only modest clinical benefit. In preclinical studies, nitrogen-containing bisphos-phonates (zoledronic acid) inhibit growth of mesothelioma cells by different me...
Alternative Titles
Full title
A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A532528782
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A532528782
Other Identifiers
ISSN
1179-2728
E-ISSN
1179-2728
DOI
10.2l47/LCTT.S135802
